Categories Analysis, Finance, U.S. Markets News
2019 might be good for derivatives after a record-breaking 2018 for CME Group
Derivatives marketplace CME Group (CME) on Thursday posted an 18% hike in 2018 average daily volume as it hit a record 19.2 million contracts. In 2018, CME Group saw 91 trading days exceed 20 million contracts, 34 days more than in 2017.
Interest rate average daily volume (ADV) for 2018 soared 22% to 9.95 million contracts, while metals ADV jumped 12% to 638,000 contracts. FX ADV rose 9% to a million contracts.
Options ADV for 2018 saw a record 3.9 million contracts, up 14%. This included electronic options ADV rising 20% to 2.6 million contracts.
In the fourth quarter of 2018, the average volume soared 31% to 20.8 million contracts per day.
December 2018 volume averaged 20.2 contracts per day, up 36%. Electronic options ADV grew 39% to 2.7 million contracts in the month, while interest rate options ADV jumped 40% to 2.4 million contracts. Equity Index options ADV soared 48% to 974,000 contracts, while agricultural options ADV inched 2% to 169,000 contracts. Metals options ADV rose 28% to 59,000 contracts.
Foreign exchange volume averaged a million contracts per day in December 2018, with Canadian dollar futures and options ADV rising 10% to 105,000 contracts, and Japanese yen futures and options inching 7% up to 177,000 contracts.
However, energy volume fell 2% as it averaged 2.3 million contracts per day in December 2018. Even though WTI Crude Oil futures and options ADV jumped 18% to 1.5 million contracts, Gasoline futures and options ADV trailed — inching just 1% higher to 174,000 contracts.
Get access to timely and accurate verbatim transcripts that are published within hours of the event
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was